EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Brookwood Pharmaceuticals subsidiary, located in Birmingham, Alabama, has acquired an additional facility in the Birmingham area. This new facility will expand Brookwood’s capacity for research and development activities and clinical manufacturing in support of customer projects. Additionally, the building will be SurModics’ corporate center for commercial GMP manufacturing of drug delivery products for pharmaceutical and biotechnology customers.
